Singapore BIOPHARMA PTE. LTD. facilitates swift market access to Greater China and Southeast Asia with professional, efficient solutions
24 Active Projects
Phase III: 6 Studies
12 Countries
3 This Quarter
25+
Years of Experience
150+
Successful Registrations
12
Countries Served
Singapore BIOPHARMA PTE. LTD. announces exclusive distribution rights for RYANODEX® (dantrolene sodium) for injectable in Singapore.
RYANODEX® is an injectable formulation indicated for the rapid treatment of malignant hyperthermia (MH).
Singapore BIOPHARMA PTE. LTD. announces exclusive distribution rights for Feraheme® (ferumoxytol injection) in Singapore.
Feraheme® is an intravenous iron formulation.
Singapore BIOPHARMA PTE. LTD. officially announces the acquisition of exclusive distribution rights for BARHEMSYS® (amisulpride) injection in Singapore.
BARHEMSYS® is an intravenous amisulpride injection specifically designed for timely and aggressive treatment of breakthrough postoperative nausea and vomiting (PONV) in patients. This product provides perioperative healthcare professionals with an effective PONV management solution.
Singapore BIOPHARMA PTE. LTD. officially announces the acquisition of exclusive distribution rights for Macrilen® (Macimorelin) in Singapore.
Macrilen® is an oral growth hormone secretagogue receptor agonist specifically designed for the diagnosis of Adult Growth Hormone Deficiency (AGHD). This product provides clinicians with a convenient and accurate diagnostic tool.
For more information, please contact:
Singapore BIOPHARMA PTE. LTD.
Email: info@biopharma.com.sg
Tel: +65 8279 4183
Comprehensive pharmaceutical solutions for healthcare providers
Advanced treatments for heart and vascular conditions
Innovative cancer treatment therapies and supportive care
Neurological disorder treatments and brain health solutions
Respiratory care products and pulmonary treatments
Our research team can develop tailored pharmaceutical products to meet your specific healthcare needs
Singapore BIOPHARMA PTE. LTD. specializes in drug registration and distribution (CSO model), drug promotion and rapid market entry, rare disease and clinically urgent drug access across 32 Chinese provinces, drug registration in mainland China, and business introductions and partnerships.
Over 100 successful drug registrations and market entries, including chemical drugs, biologics, controlled substances, CAR-T therapies, and botanical drugs.
Comprehensive Contract Sales Organization services for pharmaceutical distribution
Hong Kong-Macao Drug & Device Access and Hainan Lecheng programs
32 Chinese provinces plus Singapore, Malaysia, Indonesia, and Thailand
100+
Successful Registrations
Comprehensive pharmaceutical solutions across Greater China and Southeast Asia with expertise in registration, distribution, and rapid market access
Comprehensive CSO model services for pharmaceutical registration and distribution across target markets
Professional services including Hong Kong-Macau Drug & Device Access and Hainan Lecheng rapid market entry solutions
Specialized access solutions for rare disease and clinically urgent medications across 32 Chinese provinces
Complete regulatory support for pharmaceutical product registration in mainland China
Strategic business development and partnership facilitation across Greater China and Southeast Asia
Expertise across diverse pharmaceutical product categories with proven success records
Chemical Drugs
Biologics
Controlled Substances
CAR-T Therapies
Botanical Drugs
Years of Experience
Established pharmaceutical excellence
Successful Registrations
Successful drug registrations and market entries
Chinese Provinces
Rare disease and urgent drug access coverage
Countries Served
Greater China and Southeast Asia markets
Strategic market access across key regions with specialized programs for rapid entry
Mainland China, Hong Kong, Macau, Taiwan
Singapore, Malaysia, Indonesia, Thailand
Specialized drug and device access programs
Rapid market entry solutions
Our commitment to excellence is validated by international regulatory bodies and quality assurance organizations across our operating markets
Medical Device Quality Management
Good Manufacturing Practice
US Food & Drug Administration
Health Sciences Authority Singapore
Our biopharma engineering team has deep experience helping international companies launch in Singapore and ASEAN. We focus on registration, distribution, and promotion while keeping the agility and speed of a startup. We also collaborate with registered pharmacists and experienced medical reps to support your needs.
Specialized drug registration team covering Singapore, Malaysia, Hong Kong, Macau, and mainland China
Collaboration with 189 large hospitals across China (sales teams in every province)
Partnerships with all major medical e‑commerce platforms
Regulatory warehousing in Singapore, Hong Kong, Macau, and Guangzhou
Professional import/export operations and compliance
Agile decision‑making with startup speed and discipline
We're focused on strategic partnerships and ready to discuss how to bring your products to the region.
We value your feedback and experiences. Share your thoughts with our pharmaceutical community.
Ready to discuss pharmaceutical solutions for your healthcare needs? Our team is here to help.
Reach out to us for inquiries about our pharmaceutical products, partnerships, or research collaborations.
9 Tampines Grande, Asia Green
#02-00
Singapore 528735
+65 8279 4183
+65 8279 4183 (International)
info@biopharma.com.sg
research@biopharma.com.sg
Monday - Friday: 9:00 AM - 6:00 PM
Saturday: 9:00 AM - 1:00 PM (SGT)
Interactive Map
Tampines Grande Location